Change in number of shares and votes in Mendus AB (publ)

What we doOur approachPipelineTechnologyPublicationsPatient and Clinical Perspectives
About usExecutive ManagementBoard of DirectorsScientific Advisory Board
News & eventsPress releasesEventsInterviews
Investors
Careers

Back
Change in number of shares and votes in Mendus AB (publ)
 8:00:00 AM

Keep reading
Mendus granted US patent for use of vididencel in ovarian cancerRead